Azenta, Inc. (AZTA)
Market Cap | 3.26B |
Revenue (ttm) | 641.02M |
Net Income (ttm) | -18.75M |
Shares Out | 55.77M |
EPS (ttm) | -0.33 |
PE Ratio | n/a |
Forward PE | 154.63 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 6,698 |
Open | 59.71 |
Previous Close | 59.43 |
Day's Range | 59.23 - 59.59 |
52-Week Range | 36.01 - 69.16 |
Beta | 1.54 |
Analysts | Buy |
Price Target | 74.67 (+25.72%) |
Earnings Date | May 7, 2024 |
About AZTA
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segmen... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for AZTA stock is "Buy." The 12-month stock price forecast is $74.67, which is an increase of 25.72% from the latest price.
News
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
BURLINGTON, Mass. , March 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Virtual KeyBanc Life Sciences & MedTech Investor Forum on Tue...
Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023
BURLINGTON, Mass. , Feb. 7, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2023.
Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
BURLINGTON, Mass. , Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-fri...
Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass. , Jan. 25, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2024 earnings which ended on December 31, 2023, on Wednesday, February 7, 2024, after t...
Azenta to Host Investor Day on March 14, 2024
BURLINGTON, Mass. , Jan. 11, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Thursday, March 14, 2024 in New York City.
Azenta to Participate in the 26th Annual Needham Growth Conference
BURLINGTON, Mass. , Jan. 9, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 26th Annual Needham Growth Conference in New York, NY, on T...
Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
BURLINGTON, Mass. , Jan. 3, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will present at the 42nd Annual J.P.
Final Trade: DISH, GLD, EWJ and AZTA
The final trades of the day with the 'Fast Money' traders.
Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference
BURLINGTON, Mass. , Nov. 21, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in 1x1 meetings at the 6th Annual Evercore ISI HealthCONx Confere...
Azenta shares jump on Q4 results, buyback plans
Shares of Azenta Inc. AZTA, +0.59% jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $5...
Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023
Q4'23 reported revenue growth of 25% year over year and 2% on an organic basis FY'23 reported revenue growth of 20% and down 1% on an organic basis Q4'23 generated positive free cash flow for the seco...
Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation
Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven of the Board of Directors' ten members will have been added since...
Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project
BURLINGTON, Mass. , Nov. 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that B Medical Systems S.
Azenta to Participate in the Stephens Annual Investment Conference
BURLINGTON, Mass., Nov. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tenness...
Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast
BURLINGTON, Mass. , Nov. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2023 earnings which ended on September 30, 2023 on Monday, November 13, 2...
Azenta to Host GENEWIZ Week November 6-10, 2023
BURLINGTON, Mass. , Oct. 19, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ Week Nov...
Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value
Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.
Azenta Announces CFO Transition
Industry Veteran Herman Cueto Named CFO Azenta CFO Lindon Robertson to Retire Company Reaffirms Guidance for Fourth Quarter Fiscal 2023 BURLINGTON, Mass. , Sept. 26, 2023 /PRNewswire/ -- Azenta, Inc. ...
Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
BURLINGTON, Mass. , Sept. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in...
Azenta to Participate in the Baird 2023 Global Healthcare Conference
BURLINGTON, Mass. , Sept. 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New York, NY, o...
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023
BURLINGTON, Mass. , Aug. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana Point,...
Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference
BURLINGTON, Mass. , Aug. 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Confer...
Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023
BURLINGTON, Mass. , Aug. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2023.
Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass. , Aug. 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2023 earnings which ended on June 30, 2023 on Tuesday August 8, 2023 after the market cl...
Azenta Announces New Biorepository in the Greater Boston Area
Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint. BURLINGTON, Mass.